Access to medicines, April 30 -- As Gilead Sciences' stockholders convene today for the company's annual meeting, Doctors Without Borders/Medecins Sans Frontieres (MSF) is calling on them to push the US pharmaceutical giant to sell the highly effective HIV prevention medication lenacapavir to MSF for use in its medical projects across the world.

Published by HT Digital Content Services with permission from NGO Daily News....